Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. WYFI
5. STUB
6. SPY
7. ANDG
8. GO
9. CRS
10. EAT

Go back to Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
(NASDAQ: CNTX) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $ 
Open $0.47    52 Week Low $ 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $ 
Volume 1,260       

(NASDAQ: CNTX) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $ 
Open $0.47    52 Week Low $ 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $ 
Volume 1,260